RSUN PPT(01996)
Search documents
弘阳地产(01996.HK)预计中期亏损约20亿至25亿元
Ge Long Hui· 2025-08-20 08:48
Core Viewpoint - Hongyang Real Estate (01996.HK) expects a net loss of approximately RMB 2,000 million to RMB 2,500 million for the six months ending June 30, 2025, compared to a net loss of RMB 1,710 million in the same period of 2024 [1] Financial Performance - The anticipated net loss represents an increase compared to the previous year, primarily due to a decrease in project deliveries and lower gross profit margins from delivered projects [1] - The losses from joint ventures and associates have significantly increased compared to the same period last year [1]
弘阳地产(01996) - 盈利警告
2025-08-20 08:31
香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責,對其準 確性或完整性亦不發表任何聲明,並明確表示概不對因本公告全部或任何部分內容而產生 或因倚賴該等內容而引致的任何損失承擔任何責任。 盈利警告 本 公 告 乃 由 弘 陽 地 產 集 團 有 限 公 司(「本公司」,連 同 其 附 屬 公 司 統 稱「本集團」) 根 據 香 港 聯 合 交 易 所 有 限 公 司 證 券 上 市 規 則(「上市規則」)第13.09條及香港法例 第571章證券及期貨條例第XIVA部 項 下 的 內 幕 消 息 條 文(定 義 見 上 市 規 則)作 出。 本 公 司 董 事 會(「董事會」)謹 此 告 知 本 公 司 股 東(「股 東」)及 潛 在 投 資 者,根 據 對 本 集團截至2025年6月30日 止 六 個 月(「本期間」)最 近 可 用 的 未 經 審 核 綜 合 管 理 賬 目 的 初 步 審 閱,本 集 團 預 期 於 本 期 間 錄 得 的 虧 損 淨 額 介 乎 約 人 民 幣2,000百萬元至 人民幣2,500百 萬 元(2024年同期:虧損淨額人民幣1,710百 萬 元)。 本 期 ...
弘阳地产(01996.HK)将于8月28日召开董事会会议以审批中期业绩
Ge Long Hui· 2025-08-18 09:16
格隆汇8月18日丨弘阳地产(01996.HK)公布,公司将于2025年8月28日召开董事会会议,以(其中包括) 审议及通过集团截至2025年6月30日止六个月的中期业绩及其发布,以及审议派发中期股息的建议(如 有)。 ...
弘阳地产(01996) - 董事会会议通告
2025-08-18 08:55
香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責,對其準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明,並 明 確 表 示,概 不 對 因 本 公 告 全 部 或 任 何 部 分 內 容 而 產 生或因倚賴該等內容而引致的任何損失承擔任何責任。 Redsun Properties Group Limited 弘陽地產集團有限公司 (於開曼群島註冊成立的有限公司) (股份代號:1996) 董事會會議通告 弘 陽 地 產 集 團 有 限 公 司(「本公司」)董 事(「董 事」)會(「董事會」)謹 此 宣 佈,本 公 司 將 於2025年8月28日(星 期 四)舉 行 董 事 會 會 議,藉 以(其 中 包 括)考 慮 及 批 准 本 公 司及其附屬公司截至2025年6月30日止六個月之中期業績及其發佈,並考慮建議 派 發 中 期 股 息(如 有)。 於本公告日期,曾煥沙先生、陳彬先生及胡芳女士為執行董事;及李國棟先生、 梁又穩先生及歐陽寶豐先生為獨立非執行董事。 弘陽地產集團有限公司 曾煥沙 主 席 香港,2025年8月18日 承董事會命 ...
弘阳地产延长提早重组支持协议费用期限及基础重组支持协议费用期限
Zhi Tong Cai Jing· 2025-08-08 09:24
弘阳地产(01996)发布公告,由于若干债权人需要额外时间完成彼等加入重组支持协议的内部程序,故 公司谨此宣布,公司已行使其酌情权将提早重组支持协议费用期限由2025年8月8日下午五时正(中国香 港时间)进一步延长至2025年8月22日下午五时正(中国香港时间)(经延长提早重组支持协议费用期限)及 将基础重组支持协议费用期限由2025年8月22日下午五时正(中国香港时间)延长至2025年9月5日下午五 时正(中国香港时间)(经延长基础重组支持协议费用期限)。 ...
弘阳地产(01996)延长提早重组支持协议费用期限及基础重组支持协议费用期限
智通财经网· 2025-08-08 09:21
Group 1 - The company, Hongyang Real Estate (01996), announced an extension of the restructuring support agreement fee deadline from August 8, 2025, to August 22, 2025, due to creditors needing additional time to complete their internal procedures [1] - The basic restructuring support agreement fee deadline has also been extended from August 22, 2025, to September 5, 2025 [1]
弘阳地产(01996) - 内幕消息 - 延长提早重组支持协议费用期限及基础重组支持协议费用期限
2025-08-08 09:00
(於開曼群島註冊成立的有限公司) (股份代號:1996) 內幕消息 延長提早重組支持協議費用期限 及基礎重組支持協議費用期限 本 公 告 乃 由 弘 陽 地 產 集 團 有 限 公 司(「本公司」,連 同 其 附 屬 公 司 統 稱「本集團」) 根 據 香 港 聯 合 交 易 所 有 限 公 司 證 券 上 市 規 則(「上市規則」)第13.09條以及香港法 例第571章證券及期貨條例(「證券及期貨條例」)第XIVA部項下的內幕消息條文(定 義 見 上 市 規 則)作 出。 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責,對其準 確性或完整性亦不發表任何聲明,並明確表示概不對因本公告全部或任何部分內容而產生 或因倚賴該等內容而引致的任何損失承擔任何責任。 本公告僅供參考,並不構成收購、購買或認購本公司證券的邀請或要約。於美國或任何其他 根據任何有關司法權區證券法例登記或合資格前作出有關提呈、招攬或出售則屬不合法的 司法權區,本公告並非亦不構成提呈購買或出售或招攬購買或出售任何證券的要約的任何 部 分。本 公 告 所 述 證 券 未 曾 亦 不 會 根 據1933年 美 國 證 券 法 ...
弘阳地产(01996) - 截至二零二五年七月三十一日止股份发行人的证券变动月报表
2025-08-07 01:21
股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年7月31日 狀態: 新提交 致:香港交易及結算所有限公司 公司名稱: 弘陽地產集團有限公司 呈交日期: 2025年8月6日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 01996 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 100,000,000,000 | HKD | | 0.01 | HKD | | 1,000,000,000 | | 增加 / 減少 (-) | | | 0 | | | | HKD | | 0 | | 本月底結存 | | | 100,000,000,000 | HKD | | 0.01 | HKD | | 1,000,000,00 ...
港股公告精选|百济神州上半年营收同比增超4成 中国海外发展前7月销售额超1300亿元
Xin Lang Cai Jing· 2025-08-06 12:09
Performance Highlights - BeiGene (06160.HK) reported a revenue of 17.518 billion yuan for the first half of the year, a year-on-year increase of 46%; product revenue was 17.36 billion yuan, up 45.8%; net profit was 450 million yuan, turning from loss to profit [2] - Uni-President China (00220.HK) achieved approximately 17.087 billion yuan in revenue for the first half, a year-on-year increase of 10.6%; net profit was about 1.287 billion yuan, up 33.2% [2] - Zhiyu City Technology (09911.HK) announced a positive profit forecast, expecting mid-term revenue of approximately 3.135 to 3.215 billion yuan, a year-on-year increase of about 38.0% to 41.5%; net profit is expected to be around 470 to 510 million yuan, a year-on-year growth of approximately 108.9% to 126.7% [2] Earnings Forecasts - New World Development Company (00086.HK) expects mid-term net profit to increase to no less than 800 million HKD year-on-year [3] - Weizhi Jinkou (02003.HK) anticipates mid-term net profit exceeding 200 million HKD, a significant increase year-on-year [3] - Wing Chan Industrial (01596.HK) forecasts mid-term net profit of approximately 48.7 million HKD, turning from loss to profit [3] - Huaxian Optoelectronics (00334.HK) expects mid-term net profit to exceed 48.8 million HKD, a year-on-year increase of over 600% [3] - Maifushi (02556.HK) predicts mid-term net profit of approximately 31.8 to 41 million HKD, turning from loss to profit [4] - Xinwei Medical-B (06609.HK) expects mid-term net profit to exceed 40 million HKD, turning from loss to profit [5] - China Nuclear Technology (00611.HK) anticipates mid-term net profit growth of over 15% [6] Earnings Warnings - Hongxing Printing Group (00450.HK) expects mid-term net loss of approximately 49 million HKD, a significant increase year-on-year [7] - Zhongyu Land (01224.HK) forecasts mid-term net loss of approximately 40 million HKD, turning from profit to loss [7] - Beihai Group (00701.HK) anticipates mid-term net loss of 36 to 40 million HKD [8] Real Estate Sales Data - China Overseas Development (00688.HK) reported cumulative contract property sales of approximately 132 billion yuan for the first seven months, a year-on-year decrease of 18.3% [9] - Yuexiu Property (00123.HK) achieved cumulative contract sales of approximately 67.506 billion yuan for the first seven months, a year-on-year increase of about 11.7% [9] - Poly Property Group (00119.HK) reported contract sales of approximately 29.5 billion yuan for the first seven months, a year-on-year decrease of 13.49% [10] - China Overseas Hongyang Group (00081.HK) reported cumulative contract sales of 18.649 billion yuan for the first seven months, a year-on-year decrease of 12.2% [10] - Jindi Commercial Real Estate (00535.HK) reported cumulative contract sales of approximately 6.98 billion yuan for the first seven months, a year-on-year decrease of 37.37% [10] - Agile Group (03383.HK) reported pre-sale amount of approximately 5.69 billion yuan for the first seven months [11] - Hongyang Real Estate (01996.HK) reported cumulative contract sales of 3.208 billion yuan for the first seven months, a year-on-year decrease of 41.6% [12] - Zhengrong Real Estate (06158.HK) reported cumulative contract sales of approximately 2.701 billion yuan for the first seven months, a year-on-year decrease of 30.6% [12] - Jingrui Holdings (01862.HK) reported cumulative contract sales of approximately 571 million yuan for the first seven months, a year-on-year decrease of 52.54% [13] Company News - CITIC Securities (06030.HK) reported that its subsidiary, Huaxia Fund, achieved revenue of 4.258 billion yuan and net profit of 1.123 billion yuan in the first half, with assets under management totaling 285.1237 billion yuan [14] - Xinyi International (00732.HK) reported a cumulative operating revenue of approximately 9.566 billion HKD for the first seven months, a year-on-year decrease of about 5.3% [15] - Heng Rui Pharmaceutical (01276.HK) received orphan drug designation from the US FDA for its injection of Rikan Trastuzumab combined with Adebali for gastric cancer or gastroesophageal junction adenocarcinoma indications [15] - Fuhong Hanlin (02696.HK) completed the first patient dosing in a Phase II clinical study of HLX79 injection combined with Hanlikang® for active renal glomerulonephritis in China [15] - China Biopharmaceutical (01177.HK) announced that its self-developed TQ05105 (JAK/ROCK inhibitor) has been included in the breakthrough therapy designation program for the treatment of chronic graft-versus-host disease [15] Buyback Activities - HSBC Holdings (00005.HK) repurchased approximately 1.65 billion HKD worth of about 1.714 million shares at a price of 95.8 to 96.75 HKD [16] - Hang Seng Bank (00011.HK) spent approximately 22.6347 million HKD to repurchase 200,000 shares at a price of 112.8 to 113.6 HKD [17] - Yum China (09987.HK) repurchased approximately 6.264 million HKD worth of 16,800 shares at a price of 369.8 to 376 HKD [17]
弘阳地产前7月累计合约销售金额为32.08亿元,同比下降41.6%
Zhi Tong Cai Jing· 2025-08-06 09:05
Core Viewpoint - Hongyang Real Estate (01996) reported a significant decline in contract sales for July 2025, with a total amount of RMB 337 million, representing a year-on-year decrease of 50.4% [1] Group 1: Sales Performance - The contract sales amount for the period from January to July 2025 reached RMB 3.208 billion, showing a year-on-year decline of 41.6% [1] - The total sales area for the same period was 239,000 square meters, with an average selling price of RMB 13,428 per square meter [1] Group 2: Monthly Sales Data - In July 2025, the sales area was 25,300 square meters, with an average selling price of RMB 13,340 per square meter [1]